Completed PHASE2 INTERVENTIONAL 2-arm NCT02619084

Subthalamic Stimulation in Tourette's Syndrome (STN-DBSinTS)

Subthalamic Nucleus Deep Brain Stimulation in Tourette's Syndrome

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Conditions Gilles de la Tourette Syndrome Tourette Disorder Tourette Syndrome Tourette's Syndrome

Interventions STN DBS

Updated 5 times since 2017 Last updated: Feb 22, 2016 Started: Dec 31, 2011 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Gilles de la Tourette Syndrome and Tourette Disorder and is currently completed. Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Ministry of Health, Italy

Data source: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy